Nephrolithiasis resident survival guide: Difference between revisions
Jump to navigation
Jump to search
Line 143: | Line 143: | ||
{{familytree | | | | | | D01 | | | | | D02 | | D03 | | D01= Size |D02=Infection |D03=Obstruction }} | {{familytree | | | | | | D01 | | | | | D02 | | D03 | | D01= Size |D02=Infection |D03=Obstruction }} | ||
{{familytree | | | |,|-|-|^|-|-|.| | | |!| | | |!| | | }} | {{familytree | | | |,|-|-|^|-|-|.| | | |!| | | |!| | | }} | ||
{{familytree | | | E01 | | | | E02 | | | E03 | | E04 | | E01= | {{familytree | | | E01 | | | | E02 | | | E03 | | E04 | | E01= | ||
<div style="float: left; text-align: left; padding:1em;"> | <div style="float: left; text-align: left; padding:1em;"> <5mm | ||
</div> | </div> | ||
| E02= <div style="float: left; text-align: left; padding:1em;"> | | E02= <div style="float: left; text-align: left; padding:1em;"> >5mm | ||
</div> | </div> | ||
| E03= <div style="float: left; text-align: left; padding:1em;">❑ Broad spectrum antibiotics include coverage for: | | E03= <div style="float: left; text-align: left; padding:1em;">❑ Broad spectrum antibiotics include coverage for: | ||
*Gram (-) bacili | *[[Gram(-)]] bacili | ||
*Gram (+) cocci | *[[Gram(+)]] cocci | ||
❑ Antibacterial treatment should be administer to the results of the urine culture | ❑ Antibacterial treatment should be administer to the results of the urine culture | ||
</div> | </div> |
Revision as of 17:08, 12 February 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Andrea Tamayo Soto [2]
Definition
Causes
Life Threatening Causes
- Renal Obstruction
- Renal Isquaemia
- Renal Impairment
Common Causes[1]
- Hypercalciuria
- Hyperoxaluria
- Hypernatruria
- Hypocitraturia
- Hyperuricosuria
- Cystinuria
- Gout
- Metabolic acidosis
- Previous chemotherapy for Lymphoma and Leukemia
- Urine Infection
- Drug related stones
Management
Diagnostic Approach
Shown below is an algorithm depicting the diagnostic approach to Nephrolithiasis based on the 2014 Review of the Cleveland Clinic, urological and kidney institute.[2]
Characterize the symptoms:[3] | |||||||||||||||||||||||||
Obtain a detailed history: ❑ History of kidney stones
❑ History of UTI or pyelonephritis
❑ Diseases such as:
❑ Drug treatments and regular intake:
| |||||||||||||||||||||||||
Examine the patient: ❑ Measure the blood pressure
| |||||||||||||||||||||||||
Order labs and tests:
❑ Hemogram
❑ CT
| |||||||||||||||||||||||||
Therapeutic Approach
Shown below is an algorithm depicting the therapeutic approach to Nephrolithiasis[2][3]:
Initial Management ❑ Hydration
| |||||||||||||||||||||||||||||||||||||||||||
Complications? | |||||||||||||||||||||||||||||||||||||||||||
No | Yes | ||||||||||||||||||||||||||||||||||||||||||
Size | Infection | Obstruction | |||||||||||||||||||||||||||||||||||||||||
<5mm
| >5mm
| ❑ Ureter Obstruction:
| |||||||||||||||||||||||||||||||||||||||||
References
- ↑ Hall PM (2009). "Nephrolithiasis: treatment, causes, and prevention". Cleve Clin J Med. 76 (10): 583–91. doi:10.3949/ccjm.76a.09043. PMID 19797458.
- ↑ 2.0 2.1 Frassetto L, Kohlstadt I (2011). "Treatment and prevention of kidney stones: an update". Am Fam Physician. 84 (11): 1234–42. PMID 22150656.
- ↑ 3.0 3.1 Miller NL, Lingeman JE (2007). "Management of kidney stones". BMJ. 334 (7591): 468–72. doi:10.1136/bmj.39113.480185.80. PMC 1808123. PMID 17332586.